Drawing for SK

USPTO serial 75269647

SK

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ROSSMAN, MARY
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

D BRUCE PROUT

D BRUCE PROUT CHRISTIE PARKER & HALE LLPP O BOX 7068PASADENA, CA 91109-7068UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005acetaminophen for relief of pain; acne medications; adhesive for bandages for skin wounds; denture adhesives; adjuvants for use with vaccines; agricultural biopesticides; air deodorants; air fresheners; alcohol for topical use; algaecide for agricultural use; algaecide for swimming pools; allergy capsules; allergy medications; allergy relief medication; allergy tablets; analgesic balm; analgesics; anesthetics for surgical purposes; anesthetics for non-surgical use; anesthetics for surgical use; antacids; anthelmintics; anti-infectives; anti-inflammatories; anti-itch cream; anti-microbial handwash; antiarrhythmics; antibacterial handwash; antibacterial pharmaceuticals; antibiotic creams; antibiotic handwash; antibiotic ointments; antibiotic tablets; antibiotics; anticoagulants; anticonvulsants; antidepressants; antidotes to counteract poisons; antiemetics; antiflatulants; antihistamines; antihypertensives; antiparastics; antiseptics; antivirals; appetite suppressants; aspirin; medicated lip balm; adhesive bandages; bandages for skin wounds; bath salts for medical purposes; bee pollen for use as a dietary food supplement; bismuth preparations for pharmaceutical purposes; blood plasma, bronchial dilators; bronchodilators; burn dressings; burn relief medication; calcium channel blockers; calcium supplements; cardiovascular pharmaceuticals; cardiovascular treatment preparations; central nervous system stimulants; chemically treated papers for use in the detection of fecal occult blood; pharmaceutical preparations for use in chemotherapy; cholesterol reducers; clinical medical reagents; cold sore treatment preparations; preparations for treating colds; contact lens cleaning solutions; oral contraceptives; contrasting agent for ultrasound diagnostic imaging; cough drops; cough expectorants; cough lozenges; cough syrups; cough treatment preparations; decongestant capsules; decongestant nasal sprays; decongestants; dental abrasives; dental bleaching gels; car deodorants; household deodorants; room deodorants; dermatologicals; diagnostic preparations for clinical or medical laboratory use; diarrhea medication; diet capsules; dietary drink mixes for use as a meal replacement; dietary food supplements; dietary supplements; disinfectants for all purpose; disinfecting handwashes; diuretic preparations; domestic biopesticides; wound, burn, surgical dressings; ear drops; electrolytes; emetic preparations; excpectorants; expectorants for cough; eye drops; eye washes; nutritional additives for livestock; feminine hygiene cleansing towelettes; feminine hygiene pads; fertility enhancement preparations; fever blister treatment preparations; food for diabetics, food for enteral feeding; food for medically reatricted diets; food supplements; medicated foot powder; fungal medications; fungicides for agricultural use; fungicides for domestic use; gargles; gastro-intestinal treatment preparations; germicides for general purpose; medicated hair care preparations; hair growth stimulants; pharmaceutical preparations for the treatment of heart rhythm disorders; hemoglobin; hemorrhoid treatment preparations; hemorrhoidal ointments; herb teas for medicinal purposes, herbal supplements; herbal teas for medicinal purposes; herbicides for agricultural use; herbicides for domestic use; hormones; preparations for the suppression of hormones; veterinary vaccines for horses; hydrocortisone; hydrocortisone creams; ibuprofen for use as an oral analgesic; isulin; iodine; irrigating solutions for eye use; laxatives; lecithin for use as a dietary supplement; medicated lozenges; meal replacement and dietary supplement drink mixes; meal replacement drinks; meal replacement powders; medical adhesive tapes; medical diagnostic reagents; medical plasters; medicated lotions for skin, hair, sunburn, facial, body; medicated mouthwashes; medicated skin care preparations; menstrual symptom treatment preparations; migraine treatment preparations; mineral supplements; motion sickness treatment preparations; muscle relaxants; nail fungus treatment preparations; nasal spray preparations; nausea treatment preparations; nose drops; nutritional drink mixes for use as a meal replacement; nutritional supplements; ophthalmologic preparations; oral analgesics; pain relief medications; agricultural pesticides; domestic pesticides; corn plasters; dental polishes; pregnancy test kits for home use; psychotropics; sedatives; medicated shampoos; sleeping pills/tablets; medicated sunburn lotions; suppositories; surgical bandages; surgical dressings; throat lozenges; topical analgesic; topical anesthetics; topical gels for medical and therapeutic use; tranquilizers; transdermal drug delivery patches sold without medication; transdermal patches for use in the treatment of arthritis; vaccine adjuvants; vaccines; vitamin and mineral supplements; vitamin supplements; vitamins; wheat for use as a dietary supplement; wound dressingsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 25, 2001ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 26, 2000EX2GSOU EXTENSION 2 GRANTED—
Aug 24, 2000EXT2SOU EXTENSION 2 FILED—
Apr 28, 2000EX1GSOU EXTENSION 1 GRANTED—
Feb 24, 2000EXT1SOU EXTENSION 1 FILED—
Aug 24, 1999NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 1, 1999PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 30, 1999NPUBNOTICE OF PUBLICATION—
Jan 12, 1999CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 24, 1998DPCCDIVISIONAL PROCESSING COMPLETE—
Jun 22, 1998DRRRDIVISIONAL REQUEST RECEIVED—
Jun 22, 1998CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 22, 1997CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 1997DOCKASSIGNED TO EXAMINER—
Oct 21, 1997DOCKASSIGNED TO EXAMINER—
Oct 21, 1997DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance